MEDICLIN (0NDG) Price & Analysis

0 Followers

0NDG Stock Chart & Stats

€3.60

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€3.60

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€2.86 - €5.60

Previous CloseN/A

Volume0.00

Average Volume (3M)165.00

Market Cap

€261.25M

Enterprise Value€493.77

Total Cash (Recent Filing)€77.39M

Total Debt (Recent Filing)€382.37M

Price to Earnings (P/E)9.0

Beta-0.12

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.61

Shares Outstanding47,500,000

10 Day Avg. Volume105

30 Day Avg. Volume165

Financial Highlights & Ratios

PEG Ratio1.78

Price to Book (P/B)0.71

Price to Sales (P/S)0.22

P/FCF Ratio3.42

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.78

Revenue Forecast (FY)€805.74M

Bulls Say, Bears Say

Bulls Say

Revenue And Profitability RecoveryImproving revenue growth and a return to profitability indicate recovery in operating performance. Sustained demand across acute care, rehabilitation, and nursing services could support further earnings normalization over the next several quarters.

Consistently Positive Free Cash FlowReliable cash generation gives MEDICLIN funding for facility investment, service capacity, and debt repayment without relying entirely on external financing. Positive free cash flow also improves resilience in a regulated, capital-intensive healthcare model.

Balance Sheet ImprovementAlthough leverage remains high, the multiyear reduction in debt-to-equity and continued equity building show progress toward a stronger financial structure. This can gradually increase resilience and expand flexibility for reinvestment or debt reduction.

Bears Say

Elevated LeverageDebt remains substantial relative to equity despite recent improvement. High leverage can constrain investment, increase sensitivity to financing costs, and reduce the company’s ability to absorb weaker occupancy, reimbursement pressure, or higher staffing expenses.

Modest Operating MarginsThin margins leave limited room to absorb rising wages, energy costs, compliance spending, or unfavorable reimbursement changes. Even with improving profitability, MEDICLIN may need sustained utilization and cost control to convert revenue growth into durable earnings expansion.

Moderate Cash ConversionPositive free cash flow is supportive, but only moderate conversion means accounting earnings do not fully translate into available cash. Ongoing working-capital needs and capital expenditure could limit debt reduction and reduce flexibility during operational or regulatory pressure.

0NDG FAQ

What was MEDICLIN AG’s price range in the past 12 months?

MEDICLIN AG lowest share price was €2.86 and its highest was €5.60 in the past 12 months.

What is MEDICLIN AG’s market cap?

MEDICLIN AG’s market cap is €261.25M.

When is MEDICLIN AG’s upcoming earnings report date?

MEDICLIN AG’s upcoming earnings report date is Nov 05, 2026 which is in 61 days.

How were MEDICLIN AG’s earnings last quarter?

MEDICLIN AG released its earnings results on Jul 30, 2026. The company reported €0.206 earnings per share for the quarter.

Is MEDICLIN AG overvalued?

According to Wall Street analysts MEDICLIN AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MEDICLIN AG pay dividends?

MEDICLIN AG does not currently pay dividends.

What is MEDICLIN AG’s EPS estimate?

MEDICLIN AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MEDICLIN AG have?

MEDICLIN AG has 47,500,000 shares outstanding.

What happened to MEDICLIN AG’s price movement after its last earnings report?

MEDICLIN AG reported an EPS of €0.206 in its last earnings report. Following the earnings report the stock price went down -0.476%.

Which hedge fund is a major shareholder of MEDICLIN AG?

Currently, no hedge funds are holding shares in GB:0NDG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

MEDICLIN Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

0.73%

Trailing 12-Months

Asset Growth

-6.44%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

MEDICLIN AG

Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehensive range of medical specializations, encompassing fields such as neurology, psychosomatics, orthopaedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, and surgical interventions, in addition to general nursing care. Furthermore, Mediclin provides specialized services like ear, nose, and throat (ENT) treatment and acute outpatient care. As of December 31, 2021, its extensive network comprised 34 clinics, 7 nursing care facilities, and 11 medical care centres. This infrastructure collectively provided a significant capacity of 7,831 beds and 482 nursing places, distributed across eleven of Germany's federal states. The company's corporate headquarters are situated in Offenburg, Germany.